interstitial lung disease

February 6, 2023

Gut microbiota and lung fibrosis

Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients.

By Leigh MacMillan
April 2, 2020

Progression of inflammatory lung disease analyzed

A Vanderbilt University Medical Center interim analysis shows that there appears to be a considerable length of time before a subset of people develop inflammatory, scarring lung diseases where there is radiologically detectable evidence they will develop lung disease.

By Nancy Humphrey
October 17, 2013

Watkins lecturer reminds that medicine is all about caring

It’s all about the patient. That’s the message Talmadge King Jr., M.D., the Julius R. Krevans Distinguished Professor of Internal Medicine and chair of the Department of Medicine at the University of California, San Francisco (UCSF), shared with students, physicians, administrators and researchers during Wednesday’s Levi Watkins Jr., M.D., Lecture on Diversity in Medical Education.

By Jessica Pasley
man wearing cpap
April 13, 2012

Study examines sleep apnea’s role in lung diseases

Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases.

By Kathy Whitney